Article Text
Statistics from Altmetric.com
Commentary on: Study 1: OpenUrlCrossRefPubMedWeb of Science
Study 2: Merle CS, Fielding K, Sow OB, et al; OFLOTUB/Gatifloxacin for Tuberculosis Project. A four-month gatifloxacin-containing regimen for treating tuberculosis. N Engl J Med 2014; 371:1588–98.
Study 3: Jindani A, Harrison TS, Nunn AJ, et al; RIFAQUIN Trial Team. High-dose rifapentine with moxifloxacin for pulmonary tuberculosis. N Engl J Med 2014; 371:1599–608.
Context
Current antituberculosis therapy is a 6-month regimen that includes 2 months of isoniazid, rifampin, pyrazinamide and ethambutol, followed by 4 months of …
Footnotes
Competing interests TS serves on a data safety monitoring board for a clinical trial sponsored by Otsuka.
Provenance and peer review Commissioned; internally peer reviewed.